YI Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 30, 2026
Report Source: 2025 Annual Report
111 Inc. Stock Analysis YI
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
Read More 111 Inc (YI) Chart
Key Statistics of 111 Inc (YI)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$5.89Volume
8990.00P/E Ratio (TTM)
-52 Week Range
Market Cap
59.03MAvg. Volume
12.36KDividend Yield
-Financial Metrics & Statements of 111 Inc (YI)
FAQ's for 111 Inc (YI)
- According to Musaffa’s Shariah screening methodology, 111 Inc (YI) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.